Skip to content
Screener

Ardelyx ARDX Business Segments — Net loss

Similar metrics at other companies

Veradermics logo
MANEReportable Segment — Net loss
-$27.23M-120%
Zscaler logo
ZSReportable Segment — Net loss
-$13.88M-237%
Biohaven logo
BHVNReportable Segment — Net loss
-$130.53M+41.1%
Bicara Therapeutics logo
BCAXReportable Segment — Net loss
-$56.21M-52.6%
YSS
YSSReportable Segment — Net loss
-$114.84M-879%
Vaxcyte, Inc. logo
PCVXReportable Segment — Net loss
-$320.62M-128%

Other financials

Income statement

See full
Revenue$120.9M+23.8%
Gross profit$115.1M+35.0%
Operating income-$12.4M+13.7%
Net income-$16.7M+12.4%
EPS (diluted)-$0.07+12.5%

Balance sheet

See full
Cash & equivalents$97.2M+7.9%
Total debt$256.2M+24.0%
Total equity$149.0M+6.8%
Total assets$575.9M+23.4%

Cash flow

See full
Operating cash flow-$6.4M+74.7%
CapEx$13.0K-98.0%
Free cash flow-$6.4M+75.3%

Valuation

See full
Market cap$1.2B-4.0%
Enterprise value$1.36B-0.6%
P/S2.7×-0.6×

Profitability

See full
Gross margin94.4%+9.6pp
Operating margin-25.4%
Net margin-12.4%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.7×+0.2×
Current ratio3.3×-1.0×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: Ardelyx’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437402-26-000044
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other income, net2,0381,8924,1504,218
Loss before provision for income taxes(16,611)(19,078)(54,208)(59,363)
Provision for income taxes1101118860
Net loss$(16,721)$(19,079)$(54,326)$(60,223)
Net loss per share of common stock - basic and diluted$(0.07)$(0.08)$(0.22)$(0.25)
Shares used in computing net loss per share - basic and diluted248,067,253239,928,570246,967,275239,279,962
Comprehensive loss
Net loss$(16,721)$(19,079)$(54,326)$(60,223)

Item 1. Financial Statements (Unaudited)

FAQ

What is Ardelyx's business segments — net loss?
Ardelyx (ARDX) reported business segments — net loss of -$16.72M in Q2 2026.
How has Ardelyx's business segments — net loss changed year-over-year?
Ardelyx's business segments — net loss increased by 12.4% year-over-year, from -$19.08M to -$16.72M.
What is the long-term trend for Ardelyx's business segments — net loss?
Over 2 years (2022 to 2025), Ardelyx's business segments — net loss has grown at a -4.3% compound annual growth rate (CAGR), from -$67.21M to -$61.6M.
What does business segments — net loss mean?
The bottom-line financial result for the business segment after all revenues, expenses, and taxes have been accounted for. A net loss indicates that the costs of development and commercialization currently exceed the revenue generated. This is a critical metric for assessing the company's path to profitability and cash burn rate.

Ask your AI about Ardelyx's business segments — net loss.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude